In the present study, we observed elevated FGFR2, FRS2, and AKT activation after intranasal FGF10 delivery and AAV9‐mediated FGF10 gene delivery in 3xTg‐AD mice and APPswe‐transfected HT22 cells. The gene discussed is FGF10; the disease is Alzheimer disease.